HFSA=Heart Failure Society of America
First, these results were obtained in controlled clinical trial conditions with carefully selected participants
The most common adverse reactions reported in patients treated with semaglutide include nausea, vomiting, diarrhea, abdominal pain, and constipation.[5-7] Semaglutide may also increase the risk of pancreatitis, acute gallbladder disease, hypersensitivity reactions, acute kidney injury, and thyroid C-cell tumors.[5-7] Whether semaglutide is safe in people with pancreatitis remains unclear.[5-7] It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).[5-7] How Long Will Semaglutide Weight Loss Results Last
These outcomes made dual therapy attractive for patients with obesity and type 2 diabetes who failed to reach targets on monotherapy
However, it is crucial to emphasize that all data supporting this rationale derive from in vitro cell culture studies, in vivo animal experiments in rats and swine, and mechanistic extrapolation from established neuroendocrine physiology
Published: May 24, 2026 Written by Klarity Editorial Team Published: May 24, 2026 If youre a psychiatrist or psychiatric nurse practitioner, youve probably noticed the explosion of interest in weight-loss medicationsparticularly GLP-1 agonists like semaglutide (Wegovy/Ozempic) and tirzepatide